ABEO (Abeona Therapeutics Inc.) Prakiraan pendapatan perusahaan

Abeona Therapeutics - logo grafis emiten ABEO

The projected sales volume reflects future revenue trends, where the current metric is 0.04. Growth is driven by the global rollout of unique, high-margin gene therapies. The effective management of Abeona Therapeutics (ABEO) is successfully defending patents and engaging with the FDA. However, ultimate success depends on the final approval of the skin pathology therapy and the control of production timelines.

ABEO - Pendapatan mangsa ngarep perusahaan Abeona Therapeutics ing rentang 04.07.2022 - 17.11.2026

Rincian metrik keuangan lan pasar abeonatherapeutics.com (ABEO)

- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:Abeona Therapeutics, Inc.
Produk mawa merek Abeona Therapeutics

This indicator measures the gap between current market value and intrinsic revenue generation potential, identifying phases of asset undervaluation. For Abeona Therapeutics (ABEO), which is finalizing the market launch of its gene therapy, the projected future sales metric reflects an expected transition to high-margin cash flow following FDA approval, signaling the business's readiness for rapid scaling.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan VRTX (Vertex)|ALNY (Alnylam Pharmaceuticals, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Insmed INSM|UTHR (United Therapeutics Corp.) - Pendapatan sing dikarepake perusahaan|BioMarin Pharmaceutical - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan BBIO (BridgeBio Pharma, Inc.)|BGM Group Corp (BGM) - Prakiraan pendapatan perusahaan|Cogent Biosciences Inc (COGT) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Xeris Biopharma Inc|KROS: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan arcturusrx.com (ARCT)|Volume dodolan mangsa ngarep perusahaan Eton Pharmaceuticals ETON|Prakiraan volume dodolan KMDA (kamada.com)|Prakiraan volume dodolan Fulcrum Therapeutics, Inc. FULC|MREO - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan PLX (Protalix BioTherapeutics, Inc)|Pliant Therapeutics Inc (PLRX) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan APLT (appliedtherapeutics.com)|RNTX (Rein Therapeutics Inc.) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GELS|Volume dodolan mangsa ngarep perusahaan AYTU (aytubio.com)|Volume dodolan mangsa ngarep perusahaan Chemomab Therapeutics Ltd CMMB|Prakiraan volume dodolan SRXH (SRx Health Solutions Inc.)|Pendapatan mangsa ngarep perusahaan PLRZ|AEZS - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CYTH (CTD Holdings)|INZY: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan RPHM (Reneo Pharma)|Prakiraan pendapatan perusahaan cosciensbio.com